Ikeda A - Search Results

1

Physiologic factors that determine the health-related quality of life in patients with COPD.

Tsukino M, Nishimura K, Ikeda A, Koyama H, Mishima M, Izumi T. Tsukino M, et al. Among authors: ikeda a. Chest. 1996 Oct;110(4):896-903. doi: 10.1378/chest.110.4.896. Chest. 1996. PMID: 8874242

2

Change in generic and disease-specific health-related quality of life during a one-year period in patients with newly detected chronic obstructive pulmonary disease.

Tsukino M, Nishimura K, McKenna SP, Ikeda A, Hajiro T, Zhang M, Izumi T. Tsukino M, et al. Among authors: ikeda a. Respiration. 2002;69(6):513-20. doi: 10.1159/000066456. Respiration. 2002. PMID: 12457004

3

Nishimura K, Hajiro T, Oga T, Tsukino M, Ikeda A. Nishimura K, et al. Among authors: ikeda a. J Asthma. 2004 Feb;41(1):57-65. doi: 10.1081/jas-120024596. J Asthma. 2004. PMID: 15046379

4

Comparison of health-related quality of life measurements using a single value in patients with asthma and chronic obstructive pulmonary disease.

Nishimura K, Oga T, Ikeda A, Hajiro T, Tsukino M, Koyama H. Nishimura K, et al. Among authors: ikeda a. J Asthma. 2008 Sep;45(7):615-20. doi: 10.1080/02770900802127014. J Asthma. 2008. PMID: 18773337

5

Health status measured with the CRQ does not predict mortality in COPD.

Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Ikeda A, Mishima M. Oga T, et al. Among authors: ikeda a. Eur Respir J. 2002 Nov;20(5):1147-51. doi: 10.1183/09031936.02.00303702. Eur Respir J. 2002. PMID: 12449167 Free article.

6

Longitudinal changes in health status using the chronic respiratory disease questionnaire and pulmonary function in patients with stable chronic obstructive pulmonary disease.

Oga T, Nishimura K, Tsukino M, Hajiro T, Sato S, Ikeda A, Hamadas C, Mishima M. Oga T, et al. Among authors: ikeda a. Qual Life Res. 2004 Aug;13(6):1109-16. doi: 10.1023/B:QURE.0000031345.56580.6a. Qual Life Res. 2004. PMID: 15287277

7

Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.

Ikeda A, Nishimura K, Koyama H, Izumi T. Ikeda A, et al. Chest. 1995 Feb;107(2):401-5. doi: 10.1378/chest.107.2.401. Chest. 1995. PMID: 7842768 Clinical Trial.

8

The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.

Nishimura K, Koyama H, Ikeda A, Sugiura N, Kawakatsu K, Izumi T. Nishimura K, et al. Among authors: ikeda a. Chest. 1995 Mar;107(3):718-23. doi: 10.1378/chest.107.3.718. Chest. 1995. PMID: 7874943 Clinical Trial.

9

Oxitropium bromide improves exercise performance in patients with COPD.

Ikeda A, Nishimura K, Koyama H, Sugiura N, Izumi T. Ikeda A, et al. Chest. 1994 Dec;106(6):1740-5. doi: 10.1378/chest.106.6.1740. Chest. 1994. PMID: 7988193 Clinical Trial.

10

A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease.

Koyama H, Nishimura K, Ikeda A, Izumi T. Koyama H, et al. Among authors: ikeda a. Chest. 1993 Dec;104(6):1743-7. doi: 10.1378/chest.104.6.1743. Chest. 1993. PMID: 8252955 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,010 results

Search Page

Filters